Total Payments
$1,613
2024 Payments
$550.02
Companies
19
Transactions
98
Medicare Patients
1,719
Medicare Billing
$67,990
Payment Breakdown by Category
Food & Beverage$1,613 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,613 | 98 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $472.47 | 36 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $265.43 | 8 | $0 (2024) |
| Novo Nordisk Inc | $240.69 | 13 | $0 (2022) |
| Lilly USA, LLC | $125.93 | 9 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $88.20 | 5 | $0 (2024) |
| PFIZER INC. | $64.39 | 4 | $0 (2020) |
| Allergan, Inc. | $58.45 | 4 | $0 (2020) |
| Amgen Inc. | $54.06 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $47.35 | 3 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $36.38 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $550.02 | 28 | Otsuka America Pharmaceutical, Inc. ($236.13) |
| 2023 | $258.40 | 19 | ABBVIE INC. ($169.47) |
| 2022 | $226.04 | 15 | ABBVIE INC. ($88.99) |
| 2021 | $90.64 | 6 | Lilly USA, LLC ($59.11) |
| 2020 | $120.59 | 8 | Allergan, Inc. ($47.41) |
| 2019 | $64.16 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($17.65) |
| 2018 | $110.17 | 8 | Novo Nordisk Inc ($43.72) |
| 2017 | $193.36 | 10 | Novo Nordisk Inc ($124.38) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/03/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: VACCINE | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: UROLOGY | ||||||
| 05/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 04/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: PSYCHIATRY | ||||||
| 03/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: PSYCHIATRY | ||||||
| 02/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 203 | 408 | $14,987 | $9,021 |
| 2022 | 9 | 209 | 314 | $13,405 | $8,650 |
| 2021 | 13 | 1,032 | 1,189 | $46,821 | $34,323 |
| 2020 | 11 | 275 | 438 | $25,771 | $15,997 |
Total Patients
1,719
Total Services
2,349
Medicare Billing
$67,990
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 45 | 102 | $9,180 | $5,628 | 61.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 27 | 78 | $1,950 | $1,265 | 64.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 56 | $1,680 | $557.28 | 33.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 69 | 108 | $540.00 | $529.20 | 98.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 22 | 31 | $992.00 | $502.20 | 50.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $375.00 | $367.50 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 13 | 18 | $270.00 | $171.36 | 63.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 42 | $3,240 | $2,174 | 67.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 41 | 41 | $3,690 | $2,000 | 54.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $1,755 | $1,334 | 76.0% |
| 0013A | Adm sarscov2 100mcg/0.5ml3rd | Office | 2022 | 25 | 26 | $1,040 | $951.15 | 91.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 21 | 58 | $1,450 | $950.00 | 65.5% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 15 | 15 | $600.00 | $542.55 | 90.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 35 | $1,050 | $342.53 | 32.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 48 | 68 | $340.00 | $201.24 | 59.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 11 | 16 | $240.00 | $153.33 | 63.9% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 294 | 294 | $10,620 | $8,941 | 84.2% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 302 | 304 | $9,810 | $6,231 | 63.5% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 158 | 158 | $6,320 | $5,881 | 93.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 46 | 58 | $5,220 | $3,062 | 58.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 53 | $4,035 | $2,942 | 72.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 21 | $2,850 | $2,202 | 77.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $1,375 | $1,375 | 100.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 14 | 14 | $1,840 | $1,143 | 62.1% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 20 | 62 | $1,550 | $1,026 | 66.2% |
About Dr. Angela Powell, MD
Dr. Angela Powell, MD is a Family Medicine healthcare provider based in Monroeville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265478663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angela Powell, MD has received a total of $1,613 in payments from pharmaceutical and medical device companies, with $550.02 received in 2024. These payments were reported across 98 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,613).
As a Medicare-enrolled provider, Powell has provided services to 1,719 Medicare beneficiaries, totaling 2,349 services with total Medicare billing of $67,990. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Monroeville, AL
- Active Since 06/22/2006
- Last Updated 11/16/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1265478663
Products in Payments
- VRAYLAR (Drug) $378.82
- REXULTI (Drug) $265.43
- Tresiba (Drug) $136.81
- UBRELVY (Drug) $89.02
- Kerendia (Drug) $75.12
- TRULICITY (Drug) $51.93
- Victoza (Drug) $46.04
- Rybelsus (Drug) $41.91
- QULIPTA (Drug) $34.05
- XIFAXAN (Drug) $32.75
- EMGALITY (Drug) $30.16
- DALVANCE (Drug) $29.03
- EVENITY (Biological) $25.85
- CHANTIX (Drug) $24.96
- COLOGUARD (Device) $22.49
- Qelbree (Drug) $21.32
- Nuedexta (Drug) $19.93
- M-M-R II (Biological) $19.58
- JARDIANCE (Drug) $17.24
- EUCRISA (Drug) $16.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Monroeville
Balakrishna Ragoor, Md, MD
Family Medicine — Payments: $20,532
Family Medicine $20,532
Dr. Kristen Nardozzi, Do, DO
Family Medicine — Payments: $3,585
Family Medicine $3,585
Dr. Nufayl Khan, Md, MD
Family Medicine — Payments: $2,681
Family Medicine $2,681
Dr. Karla Cepeda, Md, MD
Family Medicine — Payments: $2,618
Family Medicine $2,618
Dr. Natalia Zavodchikov, Do, DO
Family Medicine — Payments: $1,341
Family Medicine $1,341
James Norman, Md, MD
Family Medicine — Payments: $1,309
Family Medicine $1,309